Abstract
Purpose
To investigate the blood-to-retina verapamil transport at the blood-retinal barrier (BRB).
Methods
EverFluor FL Verapamil (EFV) was adopted as the fluorescent probe of verapamil, and its transport across the BRB was investigated with common carotid artery infusion in rats. EFV transport at the inner and outer BRB was investigated with TR-iBRB2 cells and RPE-J cells, respectively.
Results
The signal of EFV was detected in the retinal tissue during the weak signal of cell impermeable compound. In TR-iBRB2 cells, the localization of EFV differed from that of LysoTracker® Red, a lysosomotropic agent, and was not altered by acute treatment with NH4Cl. In RPE-J cells, the punctate distribution of EFV was partially observed, and this was reduced by acute treatment with NH4Cl. EFV uptake by TR-iBRB2 cells was temperature-dependent and membrane potential- and pH-independent, and was significantly reduced by NH4Cl treatment during no significant effect obtained by different extracellular pH and V-ATPase inhibitor. The EFV uptake by TR-iBRB2 cells was inhibited by cationic drugs, and inhibited by verapamil in a concentration-dependent manner with an IC50 of 98.0 μM.
Conclusions
Our findings provide visual evidence to support the significance of carrier-mediated transport in the blood-to-retina verapamil transport at the BRB.
Similar content being viewed by others
Abbreviations
- ABCB1:
-
ATP-biding cassette transporter subfamily B member 1
- ABCC1:
-
ATP-biding cassette transporter subfamily C member 1
- ABCC4:
-
ATP-biding cassette transporter subfamily C member 4
- ABCG2:
-
ATP-biding cassette transporter subfamily G member 2
- ARVO:
-
Association for Research in Vision and Ophthalmology
- BCRP:
-
Breast cancer resistance protein
- BRB:
-
Blood-retinal barrier
- CH:
-
Choroid
- C/M ratio:
-
Cell-to-medium ratio
- CNG:
-
Cyclic nucleotide-gated
- DAPI:
-
4′,6-Diamidino-2-phenylindole
- ECF:
-
Extracellular fluid
- EFV:
-
EverFluor FL Verapamil (BODIPY® FL Verapamil)
- FCCP:
-
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
- FI ratio:
-
Fluorescence intensity ratio
- GCL:
-
Ganglion cell layer
- IC50 :
-
50% Inhibitory concentration
- ILM:
-
Inner limiting membrane
- INL:
-
Inner nuclear layer
- IPL:
-
Inner plexiform layer
- Km :
-
Michaelis constant
- LTR:
-
LysoTracker® Red
- MDR1:
-
Multi drug resistance 1
- MPP+ :
-
1-Methyl-4-phenylpyridinium
- MRP1:
-
Multi drug resistance-related protein 1
- MRP4:
-
Multi drug resistance-related protein 4
- Oat3:
-
Organic anion transporter 3
- Oatp1a4:
-
Organic anion transporting polypeptide 1a4
- OLM:
-
Outer limiting membrane
- ONL:
-
Outer nuclear layer
- OPL:
-
Outer plexiform layer
- PAH:
-
p-Aminohippuric acid
- PBS:
-
Phosphate-buffered saline
- P-gp:
-
P-glycoprotein
- POS:
-
Photoreceptor outer segment
- Rho-D:
-
Rhodamine B isothiocyanate-dextran
- RPE:
-
Retinal pigment epithelium
- RUI:
-
Retinal uptake index
- SLC:
-
Solute carrier
- SLCO:
-
Solute carrier organic anion
- TEA:
-
Tetraethylammonium
- V-ATPase:
-
Vacuolar-type H+-ATPase
References
Chao HM, Chidlow G, Melena J, Wood JP, Osborne NN. An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina. Brain Res. 2000;877:47–57.
Ristori C, Filippi L, Dal Monte M, Martini D, Cammalleri M, Fortunato P, et al. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Invest Ophthalmol Vis Sci. 2011;52:155–70.
Hosoya K, Tomi M, Tachikawa M. Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier. Expert Opin Drug Deliv. 2011;8:1571–87.
Cunha-Vaz JG. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res. 2004;78:715–21.
Stewart PA, Tuor UI. Blood-eye barriers in the rat: correlation of ultrastructure with function. J Comp Neurol. 1994;340:566–76.
Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Ueda M, Yanai N, et al. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp Eye Res. 2001;72:163–72.
Hosoya K, Tomi M. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol Pharm Bull. 2005;28:1–8.
Kubo Y, Obata A, Akanuma S, Hosoya K. Impact of cationic amino acid transporter 1 on blood-retinal barrier transport of L-ornithine. Invest Ophthalmol Vis Sci. 2015;56:5925–32.
Kubo Y, Yahata S, Miki S, Akanuma SI, Hosoya K. Blood-to-retina transport of riboflavin via RFVTs at the inner blood-retinal barrier. Drug Metab Pharmacokinet. 2017;32:92–9.
Kubo Y, Akanuma S, Hosoya K. Influx transport of cationic drug at the blood-retinal barrier: impact on the retinal delivery of neuroprotectants. Biol Pharm Bull. 2017;40:1139–45.
Hosoya K, Yamamoto A, Akanuma S, Tachikawa M. Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability. Pharm Res. 2010;27:2715–24.
Kubo Y, Fukui E, Akanuma S, Tachikawa M, Hosoya K. Application of membrane permeability evaluated in in vitro analyses to estimate blood-retinal barrier permeability. J Pharm Sci. 2012;101:2596–605.
Kubo Y, Kusagawa Y, Tachikawa M, Akanuma S, Hosoya K. Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier. Pharm Res. 2013;30:847–56.
Fujii S, Setoguchi C, Kawazu K, Hosoya K. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats. Invest Ophthalmol Vis Sci. 2014;55:4650–8.
Kubo Y, Shimizu Y, Kusagawa Y, Akanuma S, Hosoya K. Propranolol transport across the inner blood-retinal barrier: potential involvement of a novel organic cation transporter. J Pharm Sci. 2013;102:3332–42.
Kubo Y, Tsuchiyama A, Shimizu Y, Akanuma S, Hosoya K. Involvement of carrier-mediated transport in the retinal uptake of clonidine at the inner blood-retinal barrier. Mol Pharm. 2014;11:3747–53.
Tega Y, Kubo Y, Yuzurihara C, Akanuma S, Hosoya K. Carrier-mediated transport of nicotine across the inner blood-retinal barrier: involvement of a novel organic cation transporter driven by an outward H(+) gradient. J Pharm Sci. 2015;104:3069–75.
Chapy H, Saubaméa B, Tournier N, Bourasset F, Behar-Cohen F, Declèves X, et al. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier. Br J Pharmacol. 2016;173:497–510.
de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Commentary. Lysosomotropic agents. Biochem Pharmacol. 1974;23:2495–531.
Gong Y, Zhao Z, McConn DJ, Beaudet B, Tallman M, Speake JD, et al. Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists. Pharm Res. 2007;24:1138–44.
Nadanaciva S, Lu S, Gebhard DF, Jessen BA, Pennie WD, Will Y. A high content screening assay for identifying lysosomotropic compounds. Toxicol in Vitro. 2011;25:715–23.
Marceau F, Bawolak MT, Lodge R, Bouthillier J, Gagné-Henley A, Gaudreault RC, et al. Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs. Toxicol Appl Pharmacol. 2012;259:1–12.
Duvvuri M, Gong Y, Chatterji D, Krise JP. Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem. 2004;279:32367–72.
Kazmi F, Hensley T, Pope C, Funk RS, Loewen GJ, Buckley DB, et al. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug Metab Dispos. 2013;41:897–905.
Ohkuma S, Moriyama Y, Takano T. Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence. Proc Natl Acad Sci U S A. 1982;79:2758–62.
Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991;266:17707–12.
Lemieux B, Percival MD, Falgueyret JP. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine red DND-99. Anal Biochem. 2004;327:247–51.
Kubo Y, Seko N, Usui T, Akanuma S, Hosoya K. Lysosomal trapping is present in retinal capillary endothelial cells: insight into its influence on cationic drug transport at the inner blood-retinal barrier. Biol Pharm Bull. 2016;39:1319–24.
Crivellato E, Candussio L, Rosati AM, Bartoli-Klugmann F, Mallardi F, Decorti G. The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1. J Histochem Cytochem. 2002;50:731–4.
Troost J, Lindenmaier H, Haefeli WE, Weiss J. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells. Mol Pharmacol. 2004;66:1332–9.
Takasato Y, Rapoport SI, Smith QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Phys. 1984;247:H484–93.
Yoshida D, Todo H, Hasegawa T, Sugibayashi K. Effect of molecular weight on the dermatopharmacokinetics and systemic disposition of drugs after intracutaneous injection. Eur J Pharm Sci. 2008;35:5–11.
Egawa G, Nakamizo S, Natsuaki Y, Doi H, Miyachi Y, Kabashima K. Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep. 2013;3:1932.
Puchowicz MA, Xu K, Magness D, Miller C, Lust WD, Kern TS, et al. Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab. 2004;24:449–57.
Nabi IR, Mathews AP, Cohen-Gould L, Gundersen D, Rodriguez-Boulan E. Immortalization of polarized rat retinal pigment epithelium. J Cell Sci. 1993;104:37–49.
Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. Aust J Pharm. 1981;4:879–85.
Cook NJ, Molday LL, Reid D, Kaupp UB, Molday RS. The cGMP-gated channel of bovine rod photoreceptors is localized exclusively in the plasma membrane. J Biol Chem. 1989;264:6996–9.
Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med. 1999;5:1183–7.
Takano Y, Ohguro H, Dezawa M, Ishikawa H, Yamazaki H, Ohguro I, et al. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse. Biochem Biophys Res Commun. 2004;313:1015–22.
Bauer M, Karch R, Tournier N, Cisternino S, Wadsak W, Hacker M, et al. Assessment of P-glycoprotein transport activity at the human blood-retina barrier with (R)-11C-verapamil PET. J Nucl Med. 2017;58:678–81.
Zhang Z, Uchida Y, Hirano S, Ando D, Kubo Y, Auriola S, et al. Inner blood-retinal barrier dominantly expresses breast cancer resistance protein: comparative quantitative targeted absolute proteomics study of CNS barriers in pig. Mol Pharm. 2017;14:3729–38.
Fujii S, Setoguchi C, Kawazu K, Hosoya K. Functional characterization of carrier-mediated transport of pravastatin across the blood-retinal barrier in rats. Drug Metab Dispos. 2015;43:1956–9.
Katayama K, Ohshima Y, Tomi M, Hosoya K. Application of microdialysis to evaluate the efflux transport of estradiol 17-beta glucuronide across the rat blood-retinal barrier. J Neurosci Methods. 2006;156:249–56.
Hosoya K, Makihara A, Tsujikawa Y, Yoneyama D, Mori S, Terasaki T, et al. Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine. J Pharmacol Exp Ther. 2009;329:87–93.
Akanuma S, Hirose S, Tachikawa M, Hosoya K. Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier. Fluids Barriers CNS. 2013;10:29.
Han YH, Sweet DH, Hu DN, Pritchard JB. Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. J Pharmacol Exp Ther. 2001;296:450–7.
Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter. Mol Pharmacol. 1991;40:490–4.
Acknowledgments and Disclosures
The present study was financially supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number JP16H05110 and JP17K08409), JSPS Core-to-Core Program (B. Asia-Africa Science Platforms), and Research Grants from the Smoking Research Foundation and the Takeda Science Foundation. The authors thank Miss Reina Makino for her technical support involving confocal microscopy. The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
ESM 1
(DOC 43 kb)
Rights and permissions
About this article
Cite this article
Kubo, Y., Nakazawa, A., Akanuma, Si. et al. Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier. Pharm Res 35, 93 (2018). https://doi.org/10.1007/s11095-018-2384-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11095-018-2384-7